Nasopharyngeal carcinoma | NPC |
National Comprehensive Cancer Network | NCCN |
locoregionally advanced NPC | LA-NPC |
concurrent chemoradiotherapy | CCRT |
epidermal growth factor receptor | EGFR |
nimotuzumab | NTZ |
American Joint Committee on Cancer | AJCC |
progression-free survival | PFS |
locoregional relapse-free survival | LRRFS |
overall survival | OS |
distant metastasis-free survival | DMFS. |